hAT-1_Mam
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisThe patients were classified into two groups based on the expression levels of TE families or the identification of TE-initiated transcripts. To assess the statistical difference in survival between the two groups, a log-rank test was performed. The hazard ratio (HR) and p-value were computed using the "survdiff" function from the "survival" package in R.
Tumor | HR | P_value |
---|---|---|
TCGA-ESCA | 0.51 | 0.01 |
TCGA-STAD | 0.61 | 0.03 |
TCGA-OV | 0.81 | 0.10 |
TCGA-CHOL | 0.35 | 0.10 |
TCGA-GBM | 1.45 | 0.15 |
TCGA-LGG | 1.29 | 0.26 |
TCGA-LUSC | 1.26 | 0.32 |
TCGA-LAML | 1.28 | 0.51 |
TCGA-THCA | 0.62 | 0.63 |
TCGA-BRCA | 1.10 | 0.76 |